drugset / Trial / NCT01409148
Radioimmunoimaging of AL Amyloidosis
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of the study is to determine the capability of a radiolabeled amyloid-reactive monoclonal antibody to document the presence and distribution of amyloid deposits by PET/CT imaging in patients with AL amyloidosis.
Timeline
- Start
- 2008-11
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MU-11-1F4 124I | Monoclonal antibody | 1 mg | Intravenous |
| Subject | MU-11-1F4 124I | Monoclonal antibody | 74 mbq | Intravenous |